Integrated Filing — IndAS



General information about company
Scrip Code 500120
NSE Symbol DIAMINESQ
MSEI Symbol NA
ISIN INE591D01014
Name of company DIAMINES & CHEMICALS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 29-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 16-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 29-May-2025   12:05:00
End date and time of board meeting 29-May-2025   19:05:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-02-06
Indicate Company website link for updated RPT policy of the Company https://dacl.co.in/wp-content/uploads/2024/06/policy7.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
No default on loan and debt securities



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 178954000 713929000
Other income 10898000 37528000
Total income 189852000 751457000
2 Expenses
(a) Cost of materials consumed 76212000 327954000
(b) Purchases of stock-in-trade 0 18605000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -4201000 13826000
(d) Employee benefit expense 23669000 97601000
(e) Finance costs 1457000 3386000
(f) Depreciation, depletion and amortisation expense 7911000 31672000
(f) Other Expenses
1 Other Expenses 65262000 195289000
Total other expenses 65262000 195289000
Total expenses 170310000 688333000
3 Total profit before exceptional items and tax 19542000 63124000
4 Exceptional items 0 0
5 Total profit before tax 19542000 63124000
6 Tax expense
7 Current tax 8520000 16630000
8 Deferred tax -5143000 1621000
9 Total tax expenses 3377000 18251000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 16165000 44873000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 16165000 44873000
17 Other comprehensive income net of taxes -11747000 2471000
18 Total Comprehensive Income for the period 4418000 47344000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 97840000 97840000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 1558945000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 1.65 4.59
Diluted earnings (loss) per share from continuing operations 1.65 4.58
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.65 4.59
Diluted earnings (loss) per share from continuing and discontinued operations 1.65 4.58
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0.2091 0.2723
26 Interest service coverage ratio 0.121 0.1425
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 490452000
Capital work-in-progress 22607000
Investment property
Goodwill 0
Other intangible assets 600000
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method 301589000
Non-current financial assets
Non-current investments 0
Trade receivables, non-current
Loans, non-current 29972000
Other non-current financial assets 430000
Total non-current financial assets 30402000
Deferred tax assets (net)
Other non-current assets 31395000
Total non-current assets 877045000
2 Current assets
Inventories 316200000
Current financial asset
Current investments 0
Trade receivables, current 137748000
Cash and cash equivalents 218761000
Bank balance other than cash and cash equivalents 194724000
Loans, current 56751000
Other current financial assets
Total current financial assets 607984000
Current tax assets (net) 10825000
Other current assets 12144000
Total current assets 947153000
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 1824198000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 97840000
Other equity 1558945000
Total equity attributable to owners of parent 1656785000
Non controlling interest
Total equity 1656785000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
Total non-current financial liabilities 0
Provisions, non-current 2444000
Deferred tax liabilities (net) 43991000
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities 46435000
Current liabilities
Current financial liabilities
Borrowings, current 251000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 1407000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 85914000
Total Trade payable 87321000
Other current financial liabilities 21945000
Total current financial liabilities 109517000
Other current liabilities 9918000
Provisions, current 1543000
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 120978000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 167413000
Total equity and liabilites 1824198000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Speciality Chemicals 174132000 675599000
2 Trading in Fruits and Vegetables 4822000 38330000
Total Segment Revenue 178954000 713929000
Less: Inter segment revenue
Revenue from operations 178954000 713929000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Speciality Chemicals 37122000 68326000
2 Trading in Fruits and Vegetables -16123000 -1816000
Total Profit before tax 20999000 66510000
i. Finance cost 1457000 1457000
ii. Other Unallocable Expenditure net off Unallocable income 0 0
Profit before tax 19542000 63124000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Speciality Chemicals 1788392000 1788392000
2 Trading in Fruits and Vegetables 35806000 35806000
Total Segment Asset 1824198000 1824198000
Un-allocable Assets 0 0
Net Segment Asset 1824198000 1824198000
4 Segment Liabilities
Segment Liabilities
1 Speciality Chemicals 167413000 167413000
2 Trading in Fruits and Vegetables 0 0
Total Segment Liabilities 167413000 167413000
Un-allocable Liabilities 0 0
Net Segment Liabilities 167413000 167413000
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Gain/(Loss) on measuring equity instruments at Fair Value carried through Other Comprehensive Income (FVTOCI) -14117000 5249000
2 Remeasurement gain/(loss) on the Defined Benefit Plans 470000 -542000
Total Amount of items that will not be reclassified to profit and loss -13647000 4707000
2 Income tax relating to items that will not be reclassified to profit or loss -1900000 2236000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income -11747000 2471000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 63124000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 3386000
Adjustments for decrease (increase) in inventories -143117000
Adjustments for decrease (increase) in trade receivables, current 8538000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 0
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current -953000
Adjustments for other financial assets, current -15720000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 36105000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 31672000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 20752000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current -10968000
Adjustments for other financial liabilities, non-current -6157000
Adjustments for unrealised foreign exchange losses gains -45000
Adjustments for dividend income 1646000
Adjustments for interest income 33501000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 261000
Other adjustments to reconcile profit (loss) -889000
Other adjustments for non-cash items 815000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -111467000
Net cash flows from (used in) operations -48343000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 9144000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities -57487000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 40133000
Proceeds from sales of investment property 650000
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 150000
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 1646000
Interest received 28790000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 162366000
Net cash flows from (used in) investing activities 153469000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 125082000
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 251000
Repayments of borrowings 0
Payments of lease liabilities 0
Dividends paid 24460000
Interest paid 3386000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities 97487000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 193469000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 193469000
Cash and cash equivalents cash flow statement at beginning of period 25292000
Cash and cash equivalents cash flow statement at end of period 218761000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 K C MEHTA & CO LLP Yes 31-Mar-2027


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)
Mode of Fund Raising Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 01-Oct-2024
Amount Raised 5058000
Report filed for Quarter ended 31-Mar-2025
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review None
Comments of the auditors, if any NA
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Capital expenditures, working capital requirements, acquisition, investment in technology and for general corporate purpose NA 5058000 0 0 0 12.51 crs received up to 26.09.2024 (i.e. 25% of the issue). Note: The Company had received In-principle approval for issue not exceeding 916390 number of convertible warrants at Rs. 552 per warrant. The Company had allotted 906390 convertible warrants on receipt of subscription money Rs. 12.51 crores i.e. 25% of the total Issue, on preferential basis to the investors on 01.10.2024.


Signatory Details
Name of signatory Hemaxi Pawar
Designation of person Company Secretary
Place Vadodara
Date 29-May-2025




Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 DIAMINES AND CHEMICALS LIMITED Mr. Amit M Mehta Executive Chairman Remuneration 0 As per the Companies Act, 2013 and Shareholders' Approval 1200000 200000 8000 Textual Information(1)
2 DIAMINES AND CHEMICALS LIMITED Mr. Tanmay Godiawala Director Remuneration 0 As per the Companies Act, 2013 and Shareholders' Approval 1924000 255000 255000
3 DIAMINES AND CHEMICALS LIMITED Mr. Rajendra Chhabra Professional Director Any other transaction Sitting Fees & Professional Fees 0 As per the Companies Act, 2013 and Shareholders' Approval 772000 0 90000
4 DIAMINES AND CHEMICALS LIMITED Mr. Priyam Jhaveri Independent Director Any other transaction Sitting Fees 0 As per the Companies Act, 2013 and Shareholders' Approval 132000 0 0
5 DIAMINES AND CHEMICALS LIMITED Mr. Dhruv Mehta Independent Director Any other transaction Sitting Fees 0 As per the Companies Act, 2013 and Shareholders' Approval 130000 0 0
6 DIAMINES AND CHEMICALS LIMITED Mrs. Kejal Pandya Independent Director Any other transaction Sitting Fees 0 As per the Companies Act, 2013 and Shareholders' Approval 172000 0 0
7 DIAMINES AND CHEMICALS LIMITED Finorga (India) Private Limited Promoters Group Any other transaction Rent of Mumbai Office 0 As per agreement in compliance with the Companies Act, 2013 295000 106000 0
8 DIAMINES AND CHEMICALS LIMITED DACL Fine Chem Limited Wholly Owned Subsidiary company Loan 50000000 Unsecured Loan 7500000 49251000 56751000 Loan 0.117 Long term Unsecured For Dahej Site related activities
9 DIAMINES AND CHEMICALS LIMITED DACL Fine Chem Limited Wholly Owned Subsidiary company Any other transaction Interest receivable (gross) 0 Interest on loan 3037000 1296000 0
10 DIAMINES AND CHEMICALS LIMITED KLJ Organics Diamines limited Associates/Joint Venture Loan 630000000 Unsecured Loan 27000 25667000 25640000 Loan 0.08 Long term Unsecured Purchase of Fixed Assets and Expenses
11 DIAMINES AND CHEMICALS LIMITED KLJ Organics Diamines limited Associates/Joint Venture Any other transaction Interest receivable (gross) 0 Interst on loan 1207000 3246000 4332000
12 DIAMINES AND CHEMICALS LIMITED Reaxa Chemistry Solutions LLP Other related Party Purchase of goods or services 7500000 As per the Companies Act, 2013 43000 0 0
13 DIAMINES AND CHEMICALS LIMITED S Amit & Co. Other related Party Any other transaction Reimbursement of Exp (Net of Advance) 0 As per the Companies Act, 2013 229000 0 0
14 DIAMINES AND CHEMICALS LIMITED Reaxa Chemistry Solutions LLP Other related Party Any other transaction Job Work 1261000 As per the Companies Act, 2013 0 0 0
15 DIAMINES AND CHEMICALS LIMITED Reaxa Chemistry Solutions LLP Other related Party Sale of goods or services 4255000 As per the Companies Act, 2013 0 0 0
16 DIAMINES AND CHEMICALS LIMITED Mr. Amit M Mehta Executive Chairman Any other transaction Commission payable as per companies act 2013 0 As per the Companies Act, 2013 and Shareholders' Approval 2219000 0 0 Textual Information(2)
17 DIAMINES AND CHEMICALS LIMITED Mr. G. S. Venkatachalam Executive Director (up to 06.02.2024) Any other transaction Commission payable as per companies act 2013 0 As per the Companies Act, 2013 and Shareholders' Approval 0 0 0
18 DIAMINES AND CHEMICALS LIMITED Mr. Rajendra Chhabra Professional Director Any other transaction Commission payable as per companies act 2013 0 As per the Companies Act, 2013 and Shareholders' Approval 92000 0 0 Textual Information(3)
19 DIAMINES AND CHEMICALS LIMITED Mr. Priyam Jhaveri Independent Director Any other transaction Commission payable as per companies act 2013 0 As per the Companies Act, 2013 and Shareholders' Approval 37000 0 0 Textual Information(4)
20 DIAMINES AND CHEMICALS LIMITED Mr. Dhruv Mehta Independent Director Any other transaction Commission payable as per companies act 2013 0 As per the Companies Act, 2013 and Shareholders' Approval 37000 0 0 Textual Information(5)
21 DIAMINES AND CHEMICALS LIMITED Mrs. Kejal Pandya Independent Director Any other transaction Commission payable as per companies act 2013 0 As per the Companies Act, 2013 and Shareholders' Approval 37000 0 0 Textual Information(6)
22 DIAMINES AND CHEMICALS LIMITED Mr. Tanmay Godiawala Director Any other transaction Reimbursement of Exp (Net of Advance) 0 As per the Companies Act, 2013 462000 10000 0
23 DIAMINES AND CHEMICALS LIMITED Mr. Amit M Mehta Executive Chairman Any other transaction Rent Payment 0 As per the Companies Act, 2013 4200000 0 0
24 DIAMINES AND CHEMICALS LIMITED Mr. Amit M Mehta Executive Chairman Any other transaction Reimbursement of Exp (Net of Advance) 0 As per the Companies Act, 2013 101000 0 0
25 DIAMINES AND CHEMICALS LIMITED Mr. Amit M Mehta Executive Chairman Any other transaction Reimbursement from Related Party 0 As per the Companies Act, 2013 15000 0 11000 Textual Information(7)
Total value of transaction during the reporting period 23868000



Text Block
Textual Information(1) Closing balance is recoverable from chairman towards TDS amt. of Salary.
Textual Information(2) Commission payable for FY 2024-25
Textual Information(3) Commission payable for FY 2024-25
Textual Information(4) Commission payable for FY 2024-25
Textual Information(5) Commission payable for FY 2024-25
Textual Information(6) Commission payable for FY 2024-25
Textual Information(7) Closing balance recoverable from Related Party